Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us  
Google
Web www.equitybulls.com
Research

| More

Aarti Industries - Q4FY22 Result Update - Healthy Q4; eyes on capacity ramp-up - Accumulate

Posted On: 2022-06-06 18:36:16 (Time Zone: IST)


Nilesh Dhoot - Research Analyst Prabhudas Lilladher Pvt. Ltd.

Quick Pointers:

- Continuing shortage of nitric acid (key RM) in Q4, impacted volumes of nitric acid based products. Plans to setup concentration capacity of 225-250 TPD to mitigate supply shortfall; also evaluating a comprehensive nitric acid strategy.

- Major expansion projects (second & third long-term contract, pharma US FDA expansion, NCB capacity expansion) expected to come on-stream in FY23. Capex guidance for FY23-24 at ~Rs 30-35 bn (FY22 capex at Rs 13 bn).

- Q4FY22 Revenue/ EBITDA/ PAT growth of 45%/30%/42% YoY led by improvement in realizations (cost pass through) and volumes (restricted due to shortage of nitric acid). Commencement of revenue generation from long-term contracts and ramp-up of recently commissioned plants to drive specialty chemical revenue while pharma revenue to be driven by higher volumes from regulated markets, value-added products and new intermediate products. Upcoming projects to aid penetration in some key therapies (anti-hypertension, cardio-vascular, oncology, corticosteroids).

- We expect healthy revenue/ EBITDA/ PAT CAGR of 18%/20%/24% over FY22-24E, on increasing capacity utilization (high capex intensity of Rs 45-50 bn over FY22-24E, with focus on high value derivatives) leveraging import substitution, rising domestic demand and China +1 strategy. We assign 'Accumulate' rating with TP of Rs 880 (19x FY24E EV/EBITDA).

- Q4FY22 performance healthy, amidst challenges: Consolidated net revenue +45% YoY/ +0.6% QoQ to Rs 17.5 bn (adjusted for Rs 6.3 bn termination fees in Q3FY22) led by improvement in realizations (cost inflation pass through) and volume growth. Spec chem gross revenue was up 49% YoY/ -2% QoQ to Rs 16.3 bn while Pharmaceutical gross revenue was up 52% YoY/ 12% QoQ to Rs 3.9 bn. Gross margin - 630bps YoY/ +140bps QoQ at 47.5% on lag in full pass through of higher costs. EBITDA +30% YoY/ -5% QoQ to Rs 3.4 bn; EBITDA margin at 19.3% (-220 bps YoY / -110 bps QoQ) on higher other operating expenses. EBIT margins for pharma at 17.2% (-280bps YoY/ stable QoQ) while that for spec chem was 15.1% (-380bps YoY/ -200bps QoQ).

- Meeting takeaways: (1) Production of NCB was 19,550 mt in Q4FY22 (vs 19,100 YoY and 18,500 mt QoQ), hydrogenated products was 3,029 tpm (1935 tpm YoY and 2878 QoQ), nitro toluene was 5155 tons (vs 2935 YoY and 3630 QoQ) (2) Volume growth of 10-12% in Q4 and ~18-20% in FY22 (3) Dyes and pigments to witness weakness in demand, while agrochemicals expected to continue strong. (4) Long term contracts - Expect ~70-80% capacity utilization by FY24. Commercial manufacturing of second long-term project related contract commenced in Q4. (5) Nitric acid concentration plant (225-250 tpd) expected to commercialize plant by FY24 end (outlay Rs 1.5-2 bn on this plant). (6) NCB expansion - Phase 1 delay on logistics and labour availability issues. Phase 2 commissioning in FY23.

Shares of Aarti Industries Limited was last trading in BSE at Rs. 714.35 as compared to the previous close of Rs. 720.85. The total number of shares traded during the day was 117639 in over 9257 trades.

The stock hit an intraday high of Rs. 725.90 and intraday low of 708.50. The net turnover during the day was Rs. 84329753.00.


Click here to send ur comments or to feedback@equitybulls.com

Disclaimer:The article above is a gist / extract of the original report prepared by the research firm / brokerage firm. This article is not to be considered as an offer to sell or a solicitation to buy any securities. This article is meant for general information only. www.equitybulls.com, its employees or owners or the research firms, its employees or owners won't be responsible for any liability that may arise from information, errors or omissions in these articles. www.equitybulls.com or its employees or owners / the research firms or its employees or clients or owners may from time to time hold positions in securities referred in this article. For detailed research reports, please contact the concerned research firm directly.





Other Headlines:

CRISIL Ratings: Agrochemicals sector to see 7-9% growth amid modest exports

SBI Capital Markets: RBI Monetary Policy Dec'24 - RBI faces arduous task of managing all dynamics: Liquidity, Currency, Growth and Inflation

SBICAPS Monthly Ecocapsule Dec'24 : FY25 - A TALE OF TWO HALVES OR ONE OF FULL DESPAIR? - Executive Summary

CRISIL Ratings: Revenue growth of organised luggage makers to halve to 8-10%

CRISIL Ratings - Cement demand to grow at a moderate pace of 7-8% this fiscal

CRISIL Ratings: For small finance banks, RoA to dip ~40 bps this fiscal

Securitisation volumes witness strong growth; likely to reach ~Rs. 60,000 crore in Q2 FY2025: ICRA

CRISIL Ratings: Operating losses of state discoms to stay high despite 15-20% dip

CRISIL Ratings: Tamil Nadu garment exporters to see 8-10% revenue growth

CRISIL MI&A: Inflated natural rubber prices to puncture tyre maker margins

Infrastructure bond issuances by public sector banks to drive banks' bond issuances to an all-time high in FY2025: ICRA

CRISIL Ratings: Apparel retailers to stitch 8-10% growth with festivals, fast fashion

CRISIL Ratings: For ARCs, rising power consumption to boost recoveries from stressed operational thermal plants

Views of ICAI on SA 600 vs ISA 600

CRISIL Ratings: Wagon makers set to roll in ~20% revenue growth this fiscal

CRISIL Ratings: Basmati industry to see revenue grow ~4% on a high base this fiscal

CRISIL: Pharmaceutical sector set for 8-10% revenue growth this fiscal

CRISIL Ratings: Flexible packaging players' credit profiles to stay subdued this fiscal

Industry credit expected to grow over 12 per cent: FICCI-IBA Bankers' Survey

CRISIL Ratings: Decadal-low duty to push gold jewellery retailers' revenues up by 22-25%

CRISIL Ratings: Education loan AUM of NBFCs to top Rs 60,000 crore this fiscal

Evolving asset quality risks to impact growth and profitability of microfinance: ICRA

Near-term Consolidation; Focus Remains on Style & Sector Rotation - Axis Securities

CRISIL Ratings: Paper packaging volume to grow, but profitability to plumb lows

CRISIL MI&A: Corporate revenue growth likely moderated to 5-7% in April-June, the slowest in 15 quarters

CRISIL Ratings: Revenue growth of auto dealers to enter the slow lane this fiscal

Declining liquidity coverage ratios to slow down credit growth for banks: ICRA

CRISIL Ratings: Road developers to see slower revenue growth of 5-7% next fiscal

CRISIL Ratings: Small finance banks to grow advances 25-27% this fiscal

Global monetary easing to pick up pace - Puneet Pal, Head-Fixed Income, PGIM India Mutual Fund

Kotak Institutional Equities: Strategy: 1QFY25: Converging trends

CRISIL Ratings: Cement makers line up ~Rs 1.25 lakh crore capex over fiscals 2025-27

CRISIL Ratings: Urea import dependency to fall to 10-15% from this fiscal

CRISIL Ratings: 20% ethanol blending goal means more sugarcane utilisation

Kotak Institutional Equities: Automobiles & Components: 1QFY25 review: Steady quarter; demand outlook weakening

CRISIL MI&A: Macroeconomics First Cut - Goods exports fall, services soften

Kotak Institutional Equities: Consumer: 1QFY25 review- Uptick in staples, continued weakness in discretionary

CRISIL Ratings: Despite cash disbursement restriction gold-loan NBFCs shine

SBICAPS Report - The Green Pill: Labelled Bond Issuances, ESG Indices, Global Sustainable Funds

We expect the 10 yr benchmark bond yield to keep drifting lower gradually - PGIM India Mutual Fund

Strategy: Faith, froth and fundamentals by Kotak Institutional Equities

Earnings growth should be the key driver of returns hereon - Vinay Paharia - CIO, PGIM India Mutual Fund

IT Services: ERD services: Auto pulse-challenges ahead - Kotak Institutional Equities

Banks, Diversified Financials : Strong on expected lines across BFSI - Quarterly Review - Kotak Institutional Equities

Metals & Mining: SC ruling-empowers the states; marginal negative impact - Kotak Institutional Equities

CRISIL Ratings: Revised deposit norms unlikely to be onerous for HFCs

CRISIL Ratings: 6 gigawatt renewable energy storage to be added by fiscal 2028

CRISIL Ratings: Thermal share in power generation to dip over 500 bps next fiscal

Indian bond market issuances exceeded $105 billion, $25 billion new equity issued in FY24 - Shri Pramod Rao, ED, SEBI

One third of Nifty 100 companies hire thousands of young talent on apna.co


Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2020